register

News & Trends - MedTech & Diagnostics

Baxter to expand local manufacturing with NSW Government investment

Health Industry Hub | May 12, 2021 |

MedTech News: Baxter Healthcare, a local manufacturer of Australian made medical products, announced a major expansion of its Western Sydney advanced manufacturing facility.

Premier Gladys Berejiklian said the $250 million program from Investment NSW was an opportunity for the state to invest in its future prosperity by nurturing industries, technology and stimulating job creation.

As Australia’s only local manufacturing facility for IV medical fluids, Baxter will expand its manufacturing operations in Old Toongabbie, NSW, to strengthen Australia’s national medical supply chain and exports of Australian Made medicines to the Oceania Region.

With the funding support from NSW Government’s Job Plus program, Baxter will install a new additional production filling line for its intravenous (IV) medical fluids.

The expanded facility is expected to create approximately 80 new advanced manufacturing jobs, in addition to jobs created due to construction.

General Manager for Baxter Australia & New Zealand, Steven Flynn said “Baxter is proud to partner with the NSW Government to invest in our modern manufacturing operations in Western Sydney and create jobs in the local medtech sector.

“This major expansion of Baxter’s medical manufacturing facility will help to strengthen our national supply chain resilience and support continued export growth of Australian Made medicines.

“Baxter intravenous (IV) medicines are the backbone of medication delivery in the ICU, oncology wards, emergency rooms and operating theatres across Australia and the South Pacific.”

“As Australia’s only local manufacturer of IV medical fluids, Baxter is committed to supporting our hospitals and healthcare professionals with reliable supply of medicines during the pandemic and beyond,” Mr Flynn added.

Minister for Jobs, Investment, Tourism and Western Sydney Stuart Ayres said supporting the growth of medical technology and healthcare innovation protected lives as well as the economy.

“The pandemic put a spotlight on the value of these high-growth, essential industries and backing their growth is crucial to ensure our economy is fuelled by sustainable, knowledge-based jobs that are here for the long run,” Mr Ayres stated.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.